Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting - Université Paris Cité Access content directly
Journal Articles European Journal of Cancer Year : 2021

Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting

Katherine Francis
  • Function : Author
Val Gebski
  • Function : Author
Sarah Lord
  • Function : Author
Michael Friedlander
  • Function : Author
Chee Khoon Lee
  • Function : Author
Not file

Dates and versions

hal-03236358 , version 1 (26-05-2021)

Identifiers

Cite

Katherine Francis, Val Gebski, Sarah Lord, Michael Friedlander, Eric Pujade-Lauraine, et al.. Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting. European Journal of Cancer, 2021, 148, pp.251-259. ⟨10.1016/j.ejca.2021.02.006⟩. ⟨hal-03236358⟩
12 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More